Profound Medical (PROF) Research & Development (2024 - 2026)

Profound Medical has reported Research & Development for 3 years, with the latest figure at $5.7 million in Q2 2026.

• On a quarterly basis, Research & Development fell 7.28% year-over-year to $5.7 million in Q2 2026; TTM through Jun 2026 was $20.6 million, a 4.49% increase from a year earlier, with the FY2025 full-year figure at $20.6 million, up 21.4% from the prior year.
• Research & Development was $5.7 million for Q2 2026 at Profound Medical, up from $5.3 million in the prior quarter.
• The five-year high for Research & Development was $6.1 million in Q2 2025, with the low at $3.9 million in Q1 2024.
• Average Research & Development over 3 years is $4.8 million, with a median of $4.7 million recorded in 2024.
• The largest YoY upside for Research & Development was 45.02% in 2025 against a maximum downside of 8.11% in 2025.
• Over 3 years, Research & Development stood at $4.6 million in 2024, then dropped by 8.11% to $4.3 million in 2025, then surged by 32.35% to $5.7 million in 2026.
• The last three Research & Development figures came in at $5.7 million (Q2 2026), $5.3 million (Q1 2026), and $4.3 million (Q4 2025), per Business Quant data.